194032-43-4 Usage
General Description
(2S,5S)-2,5-DIMETHYL-PIPERAZINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER is a chemical compound with the molecular formula C13H24N2O2. It is a tert-butyl ester derivative of (2S,5S)-2,5-dimethylpiperazine-1-carboxylic acid, which is an acidic amino acid commonly used in the synthesis of peptides and pharmaceuticals. The tert-butyl ester group is often used to protect the carboxylic acid functionality and facilitate its incorporation into larger molecules. (2S,5S)-2,5-DIMETHYL-PIPERAZINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER may be used as an intermediate in organic synthesis or as a building block in the preparation of pharmaceutical compounds.
Check Digit Verification of cas no
The CAS Registry Mumber 194032-43-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,9,4,0,3 and 2 respectively; the second part has 2 digits, 4 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 194032-43:
(8*1)+(7*9)+(6*4)+(5*0)+(4*3)+(3*2)+(2*4)+(1*3)=124
124 % 10 = 4
So 194032-43-4 is a valid CAS Registry Number.
InChI:InChI=1/C11H22N2O2/c1-8-7-13(9(2)6-12-8)10(14)15-11(3,4)5/h8-9,12H,6-7H2,1-5H3/t8-,9-/m0/s1
194032-43-4Relevant articles and documents
HISTONE DEACETYLASE INHIBITORS
-
Paragraph 00172; 00173, (2018/07/29)
Provided herein are compounds and methods for inhibiting histone deacetylase ("HDAC") enzymes (e.g., HDAC1, HDAC2, and HDAC3).
ARYLPIPERAZINE OPIOID RECEPTOR ANTAGONISTS
-
Page/Page column 14, (2012/12/13)
Provided are opioid receptor antagonists represented by the formula (I) where R, Y3, R1, R2, R3, R4 and R5 are as defined herein.
1-Substituted 4-(3-Hydroxyphenyl)piperazines are pure opioid receptor antagonists
Carroll, F. Ivy,Cueva, Juan Pablo,Thomas, James B.,Mascarella, S. Wayne,Runyon, Scott P.,Navarro, Hernan A.
scheme or table, p. 365 - 369 (2010/11/18)
This report describes the discovery that 1-substituted 4-(3-hydroxyphenyl) piperazines are pure opioid receptor antagonists. Compounds in this new series include N-phenylpropyl (3S)-3-methyl-4-(3-hydroxyphenyl)piperazine and (3R)-3-methyl-4-(3-hydroxyphenyl)piperazine, both of which display low nanomolar potencies at μ, δ, and κ receptors and pure antagonist properties in a [35S]GTPγS assay.